• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 11
      2025 Research-for-Cure Academy - 17 day(s) ago

      The academy awards fellowships to up to 15 applicants to participate in a series of interactive workshops

      Source: www.iasociety.org
      Categories: General Medicine News, Infectious Disease
      Tweet Tweets with this article
      • Profile photo of 	iasociety
        iasociety

        ✋🏿 Are you an early- to mid-career #HIV investigator or #clinicalscientist? Interested in pursuing #HIVcure research? Applications are now open for the Research-for-Cure Academy taking place in #SouthAfrica this June! ✅ Learn more & apply by 23 March: https://t.co/PLUqdyAJzN

    • Mashup Score: 28
      IAS 2025 visual identity inspiration | IAS 2025 - 18 day(s) ago

      Grassroots Rwandan artist Ndayambaje Mohammed drew on Imigongo, a traditional Rwandan art form, to create a powerful artistic piece tied at its core to Rwandan culture. This piece formed the key inspiration for the IAS 2025 visual identity.

      Source: www.iasociety.org
      Categories: General Medicine News, Infectious Disease
      Tweet Tweets with this article
      • Profile photo of 	iasociety
        iasociety

        🇷🇼 Grassroots Rwandan artist Ndayambaje Mohammed drew on Imigongo, a traditional Rwandan art form, to create a powerful artistic piece tied at its core to Rwandan culture. Find out how this piece formed the inspiration for the #IAS2025 visual identity: https://t.co/XArDtPevU0

    • Mashup Score: 18
      Pre-conferences - 18 day(s) ago

      Host a pre-conference at AIDS 2024, the premier global platform to advance the HIV response

      Source: www.iasociety.org
      Categories: General Medicine News, Infectious Disease
      Tweet Tweets with this article
      • Profile photo of 	iasociety
        iasociety

        🚐 Join an #IAS2025 educational tour in #Kigali! Through experiential activities and dialogue, IAS 2025 delegates will explore local innovations, challenges and successes shaping the HIV response. ☑️ Space is limited! Learn more and sign up: https://t.co/F6pz3waPdO https://t.co/z4dBwDFjAR

    • Mashup Score: 16
      IAS 2025, the 13th IAS Conference on HIV Science | IAS 2025 - 18 day(s) ago

      IAS 2025, the 13th IAS Conference on HIV Science, will take place in Kigali, Rwanda, from 13 – 17 July 2025. An estimated 6,000 participants from around the world will attend IAS 2025. The IAS Conference on HIV Science is the world’s most influential meeting on HIV research and its applications. This biennial conference presents the critical advances in basic, clinical and operational HIV research that move science into policy and practice. Through its open and inclusive programme, the meeting sets the gold standard of HIV science, featuring highly diverse and cutting-edge research.

      Source: www.iasociety.org
      Categories: General Medicine News, HIV/AIDS
      Tweet Tweets with this article
      • Profile photo of 	iasociety
        iasociety

        7/7: Registration for the 13th IAS Conference on #HIV Science will open in November 2024. Find out more now about #IAS2025 coming to @CityofKigali, #Rwanda, in July 2025! https://t.co/1gkpzDqWpu https://t.co/3Qbpb3650R

    • Mashup Score: 1
      No, South Africa’s HIV care is not ‘under control’. To pretend so recalls the dark days of Aids denialism | Yvette Raphael and Sibongile Tshabalala - 18 day(s) ago

      It is not just Trump’s funding cuts that have led the country to a health crisis. The real collapse comes from a lack of political courage to act

      Source: www.theguardian.com
      Categories: General Medicine News, Infectious Disease
      Tweet Tweets with this article
      • Profile photo of 	iasociety
        iasociety

        🇿🇦 "No, South Africa’s HIV care is not ‘under control’. To pretend so recalls the dark days of Aids denialism" via @guardian https://t.co/NnlWZqipks

    • Mashup Score: 20
      Person-Centred Care Advocacy Academy: HIV in Europe - 19 day(s) ago

      Fellows will learn how to apply PCC principles in their settings and adapt them to the needs of their communities.

      Source: www.iasociety.org
      Categories: General Medicine News, Infectious Disease
      Tweet Tweets with this article
      • Profile photo of 	iasociety
        iasociety

        ✊🏾 Are you an HIV advocate, healthcare provider or peer educator working in #Europe? Want to advance #PersonCentredCare in the #HIV response & strengthen your advocacy skills? 📝 Apply for our PCC Advocacy Academy, taking place in Paris in October! https://t.co/rvXZiOhcNn

    • Mashup Score: 5
      South Africa is at the heart of the HIV pandemic. What happens now the money has been cut? - 19 day(s) ago

      With 12% of the population living with the virus, Trump’s sudden withdrawal of funding stands to undo decades of progress

      Source: www.theguardian.com
      Categories: General Medicine News, Infectious Disease
      Tweet Tweets with this article
      • Profile photo of 	iasociety
        iasociety

        🇿🇦 "#SouthAfrica is at the heart of the #HIV pandemic. What happens now the money has been cut?" via @guardian https://t.co/R0QPvxMjuL

    • Mashup Score: 17
      The end of the HIV epidemic is within reach - 20 day(s) ago

      MSF teams in Eswatini report success with long-acting pre-exposure prophylaxis (PrEP), which could be a turning point in ending the HIV epidemic—if people can access it.

      Source: www.doctorswithoutborders.org
      Categories: General Medicine News, Infectious Disease
      Tweet Tweets with this article
      • Profile photo of 	iasociety
        iasociety

        🇸🇿 "@MSF teams in #Eswatini report success with long-acting pre-exposure prophylaxis (PrEP), which could be a turning point in ending the #HIV epidemic—if people can access it" https://t.co/YC3ZbG3GSg

    • Mashup Score: 16
      IAS 2025, the 13th IAS Conference on HIV Science | IAS 2025 - 20 day(s) ago

      IAS 2025, the 13th IAS Conference on HIV Science, will take place in Kigali, Rwanda, from 13 – 17 July 2025. An estimated 6,000 participants from around the world will attend IAS 2025. The IAS Conference on HIV Science is the world’s most influential meeting on HIV research and its applications. This biennial conference presents the critical advances in basic, clinical and operational HIV research that move science into policy and practice. Through its open and inclusive programme, the meeting sets the gold standard of HIV science, featuring highly diverse and cutting-edge research.

      Source: www.iasociety.org
      Categories: General Medicine News, HIV/AIDS
      Tweet Tweets with this article
      • Profile photo of 	iasociety
        iasociety

        7/7: Registration for the 13th IAS Conference on #HIV Science will open in November 2024. Find out more now about #IAS2025 coming to @CityofKigali, #Rwanda, in July 2025! https://t.co/1gkpzDqWpu https://t.co/3Qbpb3650R

    • Mashup Score: 17
      The end of the HIV epidemic is within reach - 20 day(s) ago

      MSF teams in Eswatini report success with long-acting pre-exposure prophylaxis (PrEP), which could be a turning point in ending the HIV epidemic—if people can access it.

      Source: www.doctorswithoutborders.org
      Categories: General Medicine News, Infectious Disease
      Tweet Tweets with this article
      • Profile photo of 	iasociety
        iasociety

        🇸🇿 "@MSF teams in #Eswatini report success with long-acting pre-exposure prophylaxis (PrEP), which could be a turning point in ending the #HIV epidemic—if people can access it" https://t.co/YC3ZbG3GSg

    Load More

    IAS - International AIDS Society

    @iasociety

    IAS is the world's largest independent association of HIV professionals. Together we advocate and drive urgent action to reduce the global impact of HIV.

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings